Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07476079 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Optimization and Validation of Electric Acoustic Stimulation (EAS) Mapping as a Function of Residual Hearing After CI-Implantation

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion moved earlier from Dec 1, 2027 to Nov 1, 2027
    • Start date: Apr 20, 2026 to May 1, 2026
    • Eligibility criteria expanded, about 16 words
    v3
  2. Study description shortened, about 35 wordsv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this clinical study is to investigate how the fitting of an EAS (electrical acoustic stimulation) based on electrocochleography (ECochG) thresholds compares to fitting based on pure tone audiogram thresholds in terms of speech intelligibility in quiet and noise. The personal feedback from the study participants regarding the question of better fitting and the resulting sound quality should also be included in the analysis.
Trial Details
NCT Number NCT07476079
Lead Sponsor Luzerner Kantonsspital
Collaborators: MED-EL Elektromedizinische Geräte GesmbH
Conditions
(from sponsor)		 Fitting Methods by EAS Patients
Enrollment 12 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov